Jean Jacques Bienaime - Aug 12, 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Chief Executive Officer, Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Aug 12, 2022
Transactions value $
-$664,630
Form type
4
Date filed
8/16/2022, 07:36 PM
Previous filing
Jun 17, 2022
Next filing
Oct 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Sale -$379K -4K -1.19% $94.75 331K Aug 12, 2022 Direct
transaction BMRN Common Stock Sale -$286K -3K -0.91% $95.21 328K Aug 15, 2022 Direct F1
holding BMRN Common Stock 248K Aug 12, 2022 Shares held by Jean-Jacques Bienaime Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Trade made pursuant to a 10b5-1 plan executed on May 3, 2022.